abstract |
FIELD: chemistry; biochemistry. n SUBSTANCE: invention relates to biotechnology, specifically obtaining hemopoietic cells from blood, and may be used in medicine. The homopoietic cell CD34+ is extracted from peripheral blood of cancer patients undergone a growth factor treatment course. The obtained cell is transduced by a ligand which induces apoptosis with participation of the tumour necrosis factor, and is used to treat tumours. n EFFECT: invention enables to obtain a hemopoietic cell CD34+ which has anti-tumuor activity. n 6 cl, 3 dwg, 8 tbl, 3 ex |